<bill session="116" type="h" number="4710" updated="2022-11-01T03:47:36Z">
  <state datetime="2019-10-17">REFERRED</state>
  <status>
    <introduced datetime="2019-10-17"/>
  </status>
  <introduced datetime="2019-10-17"/>
  <titles>
    <title type="display">Pharmaceutical Independence Long-Term Readiness Reform Act</title>
    <title type="official" as="introduced">To direct the Secretary of Defense to include in each national defense strategy steps to strengthen the United States industrial base and to assure an uninterrupted supply of medicines, and for other purposes.</title>
    <title type="short" as="introduced">Pharmaceutical Independence Long-Term Readiness Reform Act</title>
  </titles>
  <sponsor bioguide_id="G000559"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2020-04-28"/>
    <cosponsor bioguide_id="C001055" joined="2020-05-08"/>
    <cosponsor bioguide_id="C001068" joined="2020-05-08"/>
    <cosponsor bioguide_id="E000299" joined="2019-11-08"/>
    <cosponsor bioguide_id="F000466" joined="2020-03-02"/>
    <cosponsor bioguide_id="G000584" joined="2020-02-14"/>
    <cosponsor bioguide_id="G000591" joined="2020-04-28"/>
    <cosponsor bioguide_id="H001080" joined="2020-05-12"/>
    <cosponsor bioguide_id="H001088" joined="2020-05-12"/>
    <cosponsor bioguide_id="H001053" joined="2019-10-17"/>
    <cosponsor bioguide_id="J000032" joined="2020-04-21"/>
    <cosponsor bioguide_id="J000301" joined="2020-05-19"/>
    <cosponsor bioguide_id="P000599" joined="2020-05-08"/>
    <cosponsor bioguide_id="S000522" joined="2020-05-08"/>
    <cosponsor bioguide_id="S001209" joined="2020-05-12"/>
    <cosponsor bioguide_id="S001212" joined="2020-05-05"/>
    <cosponsor bioguide_id="S001196" joined="2020-04-17"/>
    <cosponsor bioguide_id="T000470" joined="2020-05-05"/>
    <cosponsor bioguide_id="W000827" joined="2020-05-05"/>
  </cosponsors>
  <actions>
    <action datetime="2019-10-17">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-10-17">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1297-1298"/>
    </action>
    <action datetime="2019-10-17" state="REFERRED">
      <text>Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-10-17">
      <text>Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-10-17">
      <text>Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-11-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSVR" name="House Veterans' Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSVR03" name="House Veterans' Affairs" subcommittee="Health" activity="Referral"/>
    <committee code="HSBA" name="House Financial Services" subcommittee="" activity="Referral"/>
    <committee code="HSAS" name="House Armed Services" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Armed forces and national security"/>
    <term name="Buy American requirements"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Industrial policy and productivity"/>
    <term name="Manufacturing"/>
    <term name="Military medicine"/>
    <term name="Military operations and strategy"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Military readiness"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Strategic materials and reserves"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2021-02-10T21:54:08Z" status="Introduced in House">Pharmaceutical Independence Long-Term Readiness Reform Act

This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.</summary>
</bill>
